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Background: Blood transfusions in CAD are associated with increased morbidity and mortality. We evaluated the association between old and 
fresh blood transfused in an ACS population undergoing left heart catheterization (LHC).
Methods: From 11/3-6/7 9,586 pts undergoing LHC for ACS were prospectively identified. Periprocedural transfusion was defined as any 
transfusion of packed red blood cells within 10 days of LHC. Blood age was not specified in physician’s orders. Patients referred for CABG were 
excluded. Old blood was defined by age ≥21 days. The oldest unit transfused classifed new vs. fresh. All cause mortality and a composite endpoint 
(repeat revascularization, LVEF reduction by ≥20%, or ICD placement) were analyzed by multivariate and log rank analyses.
Results: Transfusion was required in 183 pts (~2% of total): 132 with fresh (Median=29day, IQR=24-35), 51 with old blood (Median=29day, 
IQR=24-35). No difference existed between groups (p=NS) for age, sex, BMI, CAD (including left main), CHF, valvular heart disease, h/o valve 
replacement, peak troponin T, and prior transfusion. By multivariate analysis, new compared to fresher blood was associated with a reduction in all-
cause mortality (HR=0.50, 95% CI 0.29-0.87 p=0.015) and composite endpoint (HR=0.53, 95% CI 0.32-0.90, p=0.017). Non-transfused patients 
were excluded by multivariate analysis,see figure.
Conclusions: In ACS, transfusing old vs. fresh blood after an early invasive strategy was associated with increased long-term mortality.
